Association of tcf7l2 allelic variations with gastric function, satiation, and glp-1 levels

Clinical and Translational Science

Volumn 4, Issue 3, 2011, Pages 183-187

  Vazquez Roque, Maria I ^a   Camilleri, Michael ^a   Vella, Adrian ^b   Carlson, Paula ^a   Laugen, Jeanette ^b   Zinsmeister, Alan R ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Gastric emptying; Gastric volume; Obesity; Prediabetes; TCF7L2

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; TECHNETIUM 99M; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; BODY MASS; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLYCEMIC CONTROL; HUMAN; IMMUNOASSAY; INGESTION; ISOTOPE LABELING; LIQUID; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MEAL; NUTRIENT UPTAKE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SATIETY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH VOLUME;

ADOLESCENT; ADULT; AGED; ALLELES; BODY MASS INDEX; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGLUCAGON; RADIONUCLIDE IMAGING; SATIATION; STOMACH; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 79959733195     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00284.x     Document Type: Review

References (37)

1. Blundell JE, Gillett A. Control of food intake in the obese. Obes Res. 2001; 9(Suppl 4): 263S-270S.
2. Deutsch JA. The role of the stomach in eating. Am J Clin Nutr. 1985; 42: 1040-1043.
3. Deutsch JA, Young WG, Kalogeris TJ. The stomach signals satiety. Science. 1978; 201: 165-167.
4. Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006; 131: 1717-1724.
5. Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I, Baxter K, Burton D, Zinsmeister AR. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol. 2005; 3: 997-1006.
6. Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I, Camilleri M. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004; 126: 432-440.
7. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem.. 2005; 280: 1457-1464.
8. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol. 2002; 282: G424-G431.
9. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil. 2003; 15: 435-443.
10. Gautier JF, Choukem SP, Girard J. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab. 2008; 34(Suppl. 2): S65-S72.
11. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38: 320-323.
12. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007; 85: 777-782.
13. Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnardsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet. 2007; 39: 218-225.
14. Humphries SE, Gable D, Cooper JA, Ireland H, Stephens JW, Hurel SJ, Li KW, Palmen J, Miller MA, Cappuccio FP, et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med. 2006; 84: 1-10.
15. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006; 355: 241-250.
16. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, Mitchell BD, Shuldiner AR. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes. 2006; 55: 2654-2659.
17. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjögren M, Florez JC, Almgren P, Isomaa B, Orho-Melander M, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes. 2006; 55: 2890-2895.
18. Zhao J, Schug J, Li M, Kaestner KH, Grant SF. Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Diabetologia. 2010; 53: 2340-2346.
19. Pilgaard K, Jensen CB, Schou JH, Lyssenko V, Wegner L, Brøns C, Vilsbøll T, Hansen T, Madsbad S, Holst JJ, et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia. 2009; 52: 1298-1307.
20. Schafer SA, Tschritter O, Machicao F, Thamer C, Sefan N, Gallwitz B, Holst JJ, Dekker JM, t Hart LM, Nijpels G, et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia. 2007; 50: 2443-2450.
21. Papathanasopoulos A, Camilleri M, Carlson P, Vella A, Linker Nord S, Burton D, Odunsi S, Zinsmeister AR. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity. 2010; 18: 1201-1211.
22. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, Burton DD, Braddock AE, Clark MM, Graszer KM, et al. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology. 2008; 135: 1142-1154.
23. Grudell AB, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, Baxter K, Zinsmeister AR. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil. 2008; 20: 213-219.
24. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther. 2002; 16: 1781-1790.
25. Bouras EP, Delgado-Aros S, Camilleri M, Castillo EJ, Burton DD, Thomforde GM, Chial HJ. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut. 2002; 51: 781-786.
26. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil. 2004; 16: 567-573.
27. Breen M, Camilleri M, Burton D, Zinsmeister AR. Performance characteristics of the measurement of gastric volume using single photon emission computed tomography. Neurogastroenterol Motil. 2011; 23: 308-315.
28. Chial HJ, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, Camilleri M. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil. 2002; 14: 249-253.
29. Maddern GJ, Jamieson GG. Fundoplication enhances gastric emptying. Ann Surg. 1985; 201: 296-299.
30. Jamieson GG, Maddern GJ, Myers JC. Gastric emptying after fundoplication with and without proximal gastric vagotomy. Arch Surg. 1991; 126: 1414-1417.
31. Pacilli M, Pierro A, Lindley KJ, Curry JI, Eaton S. Gastric emptying is accelerated following laparoscopic Nissen fundoplication. Eur J Pediatr Surg. 2008; 18: 395-397.
32. Miholic J, Hoffmann M, Holst JJ, Lenglinger J, Mittlböck M, Bergmann H, Stacher G. Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication. Surg Endosc. 2007; 21: 309-314.
33. Moragas G, Azpiroz F, Pavia J, Malagelada JR. Relations among intragastric pressure, postcibal perception, and gastric emptying. Am J Physiol. 1993; 264: G1112-G1117.
34. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001; 24: 371-381.
35. Lee S, Lee CE, Elias CF, Elmquist JK. Expression of the diabetes-associated gene TCF7L2 in adult mouse brain. J Comp Neurol. 2009; 517: 925-939.
36. Reimann F, Gribble FM. Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes. 2002; 51: 2757-2763.
37. Villareal DT, Robertson H, Bell GI, Patterson BW, Tran H, Wice B, Polonsky KS. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes. 2010; 59: 479-485.